INO•prnewswire•
INOVIO Reports Inducement Grant Under Inducement Plan
Summary
PLYMOUTH MEETING, Pa., Dec. 19, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 19, 2025 by prnewswire